About OliX Pharmaceuticals, Inc.

Website
Website
Employees
Employees
51-200 employees View all
Industry
Industry
Pharmaceuticals
Location
Location
Ace Gwanggyo Tower1, Suite 1014, 17, Daehak 4-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do 16226, KR
Description
Information
Accelerating Drug Development using Oligonucleotides Since its discovery, RNA interference (RNAi) technology has been widely recognized as a novel drug development platform that could change the paradigm of therapeutic development. OliX Pharmaceuticals is a clinical stage pharmaceutical company developing therapeutics based on the science of RNAi to address a wide variety of illnesses. The Company has developed core platforms (asymmetric siRNA, cell-penetrating asiRNA) targeting locally administrable diseases, such as hypertrophic scars, hair loss, and age-related macular degeneration (AMD). OliX's third RNAi therapeutic platform, GalNAc-asiRNA, targets multiple liver diseases, including NASH/diabetes and HBV. For the general welfare of human beings, OliX is constantly endeavoring to become a leader in the global biotechnology industry by innovating and expanding its pipeline, even to the undruggable diseases.

OliX Pharmaceuticals, Inc. Alternatives

Frequently Asked Questions about OliX Pharmaceuticals, Inc.

What is OliX Pharmaceuticals, Inc. email format?

The widely used OliX Pharmaceuticals, Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is OliX Pharmaceuticals, Inc. customer service number?

To contact OliX Pharmaceuticals, Inc. customer service number call here +82-31-779-8400. To contact OliX Pharmaceuticals, Inc. customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more